Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21.
Nahi H, Våtsveen TK, Lund J, Heeg BM, Preiss B, Alici E, Møller MB, Wader KF, Møller HE, Grøseth LA, Østergaard B, Dai HY, Holmberg E, Gahrton G, Waage A, Abildgaard N.
Nahi H, et al.
Eur J Haematol. 2016 Jan;96(1):46-54. doi: 10.1111/ejh.12546. Epub 2015 Jun 29.
Eur J Haematol. 2016.
PMID: 25779478